TP53 and neoplasm: They are abundant in the TME and inhibit CTL-driven anti-tumor responses.Currently, there are fewer studies on the mechanisms through which p53 regulates Tregs to influence antitumor immunity; however, in recent years, increasing evidence has suggested that Mut p53 promotes tumor immune escape by affecting Treg cell differentiation.